RESUMEN
Gut resection is followed by wide changes in the gastrointestinal tract. The goal is to increase nutrient, water and mineral absorption in the remnant intestine. These changes are going on for several months. They affect gut mucosa structure, intestine peristaltic activity and enterocytes function. The crucial role is ileum preserving. Ileum has higher adaptation ability comparing to jejunum and inhibits peristaltic function of proximal parts of GIT. A lot of factors involved in intestinal adaptation were identified, hormones, growth factors, regulating peptides, intracellular signalizing cascades, cytokines and tissue factors. The most important seems to be GLP2 (glucagon like peptide 2) which has positive trophic influence on gut mucosa. Early enteral nutrition after gut resection enhances its adaptation. Recombinant analogueGLP2 teduglutide was introduced to be used in the short bowel syndrome treatment. It inhibits stomach evacuation and hypersecretion, increases intestine perfusion and enhances intestinal adaptation. Its long-term application accelerates the parenteral nutrition weaning.Key words: enteral nutrition - enterocytes - GLP2 - gut resection - intestinal adaptation.
Asunto(s)
Adaptación Fisiológica/fisiología , Síndrome del Intestino Corto/fisiopatología , Animales , Humanos , Intestino Delgado/cirugíaRESUMEN
Nowadays, there is increasing evidence showing that the development of the metabolic syndrome combining obesity, type 2 diabetes mellitus, arterial hypertension and dyslipidemia involves except of traditional risk factors (overnutrition, lack of physical activity, genetic predisposition) also the effect of environmental organic substances called organic pollutants or endocrine disruptors. These chemicals can be found in plastic covers, paints, flame retardants, exhaust gases, fertilizers as well as diverse daily utensils. Phthalates, used primarily as plasticizers, and bisphenol A, are among the most wide-spread members of this group.The aim of this article is to provide a basic overview of the relationship between phthalates and bisphenol A and the etiopathogenesis of the metabolic syndrome and to highlight their potential sources. According to the analysis of materials used for parenteral nutrition and urinary excretion of phthalate metabolites and bisphenol A in subjects on long-term parenteral nutrition we suppose that currently used medical materials are safe with respect to the exposure to both phthalates and bisphenol A and that home environment, especially cosmetic products, might constitute a more probable source of these substances.
Asunto(s)
Compuestos de Bencidrilo/efectos adversos , Disruptores Endocrinos/efectos adversos , Exposición a Riesgos Ambientales/efectos adversos , Contaminantes Ambientales/efectos adversos , Trastornos del Metabolismo de la Glucosa/inducido químicamente , Fenoles/efectos adversos , Ácidos Ftálicos/efectos adversos , Diabetes Mellitus Tipo 2/inducido químicamente , Diabetes Mellitus Tipo 2/fisiopatología , Trastornos del Metabolismo de la Glucosa/fisiopatología , Humanos , Síndrome Metabólico/inducido químicamente , Síndrome Metabólico/fisiopatología , Obesidad/inducido químicamente , Obesidad/fisiopatologíaRESUMEN
UNLABELLED: All-in-one (AIO) admixtures for parenteral nutrition are common in hospital pharmacy practices. They are extemporaneously prepared and should be stable during preparation, storage, and administration. Lipid emulsion is a clinically important and very susceptible component of instability. The objective of study was to evaluate the long-term stability of AIO admixtures containing modern lipid emulsions. MATERIAL AND METHODS: AIO admixtures with two different emulsions (SMOFlipid and Lipoplus) containing the same amount of glucose and complex amino acid solution, and variable amounts of ions were prepared. Samples were evaluated at 2, 5, 8 and 30 days after preparation. The main indicator of AIO system stability was the amount of lipid globules greater than 5 µm in diameter, which is limited by pharmacopoeia. Optical microscopy was used for particle size measurement. RESULTS: All prepared AIO admixtures remained stable during observation. The counts of overlimit lipid particles were within pharmacopeial limit nevertheless tended to increase in time. After 30-day storage, their value was influenced mainly by concentration of calcium ions, which at lower concentrations had a greater impact on SMOFlipid-based admixtures, whereas at the highest concentration on Lipoplus-based admixtures. The concentration of ions and osmolarity remained without changes; pH of admixtures slightly decreased. CONCLUSIONS: Both lipid emulsions were found to be suitable for preparation AIO admixtures with different concentrations of electrolytes. The formulations were stable even if contained high concentrations of divalent ions. The comparison of emulsions revealed the superiority of Lipoplus - electrolyte concentrations and duration of storage had a greater impact on admixtures with SMOFlipid.
Asunto(s)
Lípidos/química , Soluciones para Nutrición Parenteral/química , Estabilidad de Medicamentos , Almacenaje de Medicamentos , Emulsiones , Hospitales , Concentración de Iones de Hidrógeno , Infertilidad , Servicio de Farmacia en HospitalRESUMEN
We present a case report of intoxication by a potentially lethal dose of sustained-release verapamil with delayed escalation of complications. The patient was hospitalized 1.5 h after an attempted suicide with a very high dose of verapamil sustained-release (7.2 g). On admission the plasma concentrations were extremely high (3600 ng/l). Heart rate and blood pressure declined slowly with a surprising sudden escalation on the third day coupled with hemodynamic collapse and loss of consciousness. Complete recovery was achieved in spite of 2 h of extreme hypotension. We outline the clinical course, a need for massive bowel irrigation in case of sustained-release medication, the timing of a temporary pacing and the effect of centralization of circulation even on invasively measured blood pressure.
Asunto(s)
Bloqueadores de los Canales de Calcio/envenenamiento , Coma/inducido químicamente , Verapamilo/envenenamiento , Anciano , Determinación de la Presión Sanguínea , Preparaciones de Acción Retardada/envenenamiento , Humanos , Hipotensión/inducido químicamente , Hipotensión/diagnóstico , Masculino , Intento de SuicidioRESUMEN
Soluble leptin receptor is an extracellular domain of the leptin receptor that serves as the main leptin-binding protein and may play a role in the regulation of leptin tissue effects. The aim of our study was to assess serum concentrations of leptin, soluble leptin receptor, and other hormones involved in the regulation of leptin secretion in pregnant women before and after delivery. Serum leptin, cortisol, and tumor necrosis factor alpha (TNF-alpha) concentrations in 19 pregnant women before delivery were significantly higher than in healthy nonpregnant women (33.3+/-21.0 vs. 7.9+/-3.5 ng/mL, 1068.9+/-442.2 vs. 546.6+/-165.3 nmol/L, 4.4+/-1.1 vs. 3.4+/-1.2 ng/mL, respectively). In contrast, no differences between these groups were found in soluble leptin receptor levels. Delivery significantly decreased serum leptin and cortisol levels and increased soluble leptin receptor levels (12.3+/-9.1 ng/mL, 749.6+/-205.3 nmol/L, 23.3+/-7.9 U/mL, respectively). Soluble leptin receptor levels after delivery became higher than in the control group. We conclude that serum leptin and serum soluble leptin-receptor levels are significantly affected by pregnancy and delivery. The regulation of leptin levels in this group of patients appears to be distinct and independent of soluble leptin-receptor levels.
Asunto(s)
Leptina/sangre , Parto/sangre , Embarazo/sangre , Receptores de Superficie Celular/sangre , Femenino , Humanos , Hidrocortisona/sangre , Receptores de Leptina , Valores de Referencia , Factor de Necrosis Tumoral alfa/análisisRESUMEN
OBJECTIVE: To examine whether changes of serum soluble leptin receptor levels (S-LEPR) can modify leptin half-life and its tissue effects. The aim of our study was to measure S-LEPR levels in patients with anorexia nervosa (AN) before and 6 weeks after partial refeeding. METHODS: Anthropometric variables, serum leptin, S-LEPR, insulin, cortisol and TNF-alpha were measured in 15 AN patients before and after partial refeeding and 15 healthy control women. RESULTS: S-LEPR levels in AN patients were significantly higher than in healthy subjects (26.8 +/- 8.1 vs. 16.36+/-2.6U/mL, p < 0.01) and were not affected by partial refeeding (26.8 +/- 8.1 vs. 24.2 +/- 6.1 U/mL). In contrast, body mass index (BMI), body fat content, and serum leptin levels in AN patients increased significantly after partial refeeding. Except for the inverse relationship of S-LEPR levels to BMI and body fat content no clear relationship of this parameter to serum leptin, cortisol, insulin or TNF-alpha was found. CONCLUSION: S-LEPR levels are significantly increased in AN patients and this increase is unaffected by partial refeeding. The possibility of etiological role of increased S-LEPR levels in AN patients by affecting leptin central and/or peripherial effects should be further elucidated.
Asunto(s)
Anorexia Nerviosa/sangre , Receptores de Superficie Celular/sangre , Tejido Adiposo/patología , Anorexia Nerviosa/patología , Composición Corporal , Índice de Masa Corporal , Femenino , Alimentos , Humanos , Insulina/sangre , Leptina/sangre , Receptores de Superficie Celular/química , Receptores de Leptina , Valores de Referencia , SolubilidadRESUMEN
Ghrelin is a novel peptide hormone which was identified as an endogenous growth hormone secretagogue. It is mainly secreted in the stomach, but important sites of its secretion are other parts of the gastrointestinal tract. Ghrelin is thought to be involved not only in regulation of growth hormone secretion but also in regulation of food intake and nutritional status. This study was aimed to investigate the changes in plasma ghrelin levels in patients with short bowel syndrome. Twenty-four patients with malnutrition due to short bowel syndrome and eleven healthy controls were included in the study. They underwent clinical examination and assessment of plasma or serum levels of ghrelin leptin, soluble leptin receptor, IGF-I, IGFBP-1 and IGFBP-3. Plasma ghrelin levels were decreased in patients with short bowel syndrome (p<0.01). Furthermore, decreased serum levels of IGF-I (p<0.01) and IGFBP-3 (p<0.001) were found in patients with short bowel syndrome. Other laboratory differences between both groups were not significant. No relationship between ghrelin and other determined variables was found. We conclude that plasma ghrelin levels are decreased in the group of patients with short bowel syndrome. It is probably because of a decrease in the tissue mass that is able to secrete ghrelin.